About Klinikum Braunschweig; Medizinische Klinik III; Klinik für Hämatologie und Onkologie
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Clinical Trials at Klinikum Braunschweig; Medizinische Klinik III; Klinik für Hämatologie und Onkologie
During the past decade, Klinikum Braunschweig; Medizinische Klinik III; Klinik für Hämatologie und Onkologie conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on
average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Klinikum Braunschweig; Medizinische Klinik III; Klinik für Hämatologie und Onkologie
According to Clinical.Site data, the most researched conditions in "Klinikum Braunschweig; Medizinische Klinik III; Klinik für Hämatologie und Onkologie" are
"Gastric Cancer" (1 trials), "Leukemia, Myeloid, Acute" (1 trials) and "Non-small Cell Lung Cancer (NSCLC)" (1 trials). Many other conditions were trialed in "Klinikum Braunschweig; Medizinische Klinik III; Klinik für Hämatologie und Onkologie" in a lesser frequency.
Clinical Trials Intervention Types at Klinikum Braunschweig; Medizinische Klinik III; Klinik für Hämatologie und Onkologie
Most popular intervention types in "Klinikum Braunschweig; Medizinische Klinik III; Klinik für Hämatologie und Onkologie" are "Drug" (3 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Atezolizumab" (1 trials), "Capecitabine" (1 trials), "Cisplatin" (1 trials), "Cytarabine" (1 trials) and "Durvalumab" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Klinikum Braunschweig; Medizinische Klinik III; Klinik für Hämatologie und Onkologie
The vast majority of trials in "Klinikum Braunschweig; Medizinische Klinik III; Klinik für Hämatologie und Onkologie" are
3 trials for "All" genders.
Clinical Trials Status at Klinikum Braunschweig; Medizinische Klinik III; Klinik für Hämatologie und Onkologie
Currently, there are NaN active trials in "Klinikum Braunschweig; Medizinische Klinik III; Klinik für Hämatologie und Onkologie".
undefined are not yet recruiting,
undefined are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in Klinikum Braunschweig; Medizinische Klinik III; Klinik für Hämatologie und Onkologie,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Klinikum Braunschweig; Medizinische Klinik III; Klinik für Hämatologie und Onkologie, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".